AEON Biopharma (AEON) Institutional Ownership → The Worst is Yet to Come… (From Porter & Company) (Ad) Free AEON Stock Alerts $1.53 +0.03 (+2.00%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for AEON Biopharma (NASDAQ:AEON)CurrentInstitutional OwnershipPercentage22.78%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$27.31MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$10.43M Get AEON Insider Trade Alerts Want to know when executives and insiders are buying or selling AEON Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AEON Institutional Buying and Selling by Quarter Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… AEON Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Shaolin Capital Management LLC21,380$248K0.0%-97.7%0.057% 5/10/2024 Vanguard Group Inc.758,992$8.80M0.0%+261.8%2.008% 2/7/2024 Formidable Asset Management LLC58,193$419K0.1%-9.5%0.157% 11/9/2023 Formidable Asset Management LLC64,311$360K0.1%N/A0.723% 11/6/2023 Atalaya Capital Management LP3,675,000$19.83M21.7%N/A41.283% (Data available from 1/1/2016 forward) AEON Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AEON shares? During the previous two years, the following institutional investors and hedge funds held shares of AEON Biopharma shares: Atalaya Capital Management LP ($19.83M), Vanguard Group Inc. ($8.80M), and Formidable Asset Management LLC ($419K), Shaolin Capital Management LLC ($248K).Learn more on AEON's institutional investors. What percentage of AEON Biopharma stock is owned by institutional investors? 22.78% of AEON Biopharma stock is owned by institutional investors. Learn more on AEON's institutional investor holdings. Which institutional investors have been buying AEON Biopharma stock? The following institutional investors have purchased AEON Biopharma stock in the last 24 months: Atalaya Capital Management LP ($3.68M), Vanguard Group Inc. ($549.21K), and Formidable Asset Management LLC ($64.31K). How much institutional buying is happening at AEON Biopharma? Institutional investors have bought a total of 4,288,518 shares in the last 24 months. This purchase volume represents approximately $27.31M in transactions. Which AEON Biopharma major shareholders have been selling company stock? The following institutional investors have sold AEON Biopharma stock in the last 24 months: Shaolin Capital Management LLC ($895.74K), and Formidable Asset Management LLC ($6.12K). How much institutional selling is happening at AEON Biopharma? Institutional investors have sold a total of 901,858 shares in the last 24 months. This volume of shares sold represents approximately $10.43M in transactions. Related Companies: EGRX Major Shareholders CARM Major Shareholders KRON Major Shareholders CALC Major Shareholders ANEB Major Shareholders IMMX Major Shareholders ELDN Major Shareholders TLSA Major Shareholders KZR Major Shareholders ALRN Major Shareholders This page (NASDAQ:AEON) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsProtect Your Bank Account Before It’s Too LateWeiss RatingsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.